Development of the Novel FLOX Score to Assess Risk of Intubation in Children With Immunocompromising Conditions Receiving High Flow Nasal Cannula
Pediatric Pulmonology · 2026
DOI: 10.1002/ppul.71814 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Pulmonology, 2026. Verfasst von Michelle A Mai und 2 weiteren Autor:innen. Beteiligte Einrichtung: Indiana University School of Medicine, Indianapolis, Indiana, USA. Hauptthemen laut MEDLINE: Cannula, Immunocompromised Host, Intubation, Intratracheal, Oxygen Inhalation Therapy. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, National Heart, Lung, and Blood Institute.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
Heated, humidified, high‐flow nasal cannula (HFNC) before intubation has been associated with increased mortality in children with immunocompromising conditions (ICC).
Objectives
We sought to describe HFNC failure (intubation) rate and aimed to develop a novel score associated with HFNC failure.
Methods
This is a single center, retrospective cohort. Patients (aged 0–26 years) with ICCs who used HFNC between 2021 and 2023 were included.
Results
Forty‐four (47.3%) of 93 included subjects failed HFNC. PICU mortality was 14% ( n = 13). The median duration of HFNC was 18.7 h (IQR: 6.0, 40.4). We developed the novel FLOX ((flow in Liters/minute)/weight (kg)*FiO 2 ) score. Median FLOX score was higher with HFNC failure at initiation ( p = 0.04), 2 h ( p = 0.03), 4 h ( p = 0.05), and 6 h ( p = 0.05). Adjusting for acuity, the odds of HFNC failure with a FLOX score (≥0.20) were as follows: Initiation OR = 2.5 (95%CI: 1.03, 5.9), p = 0.042); 2 h of HFNC, OR = 4.3 ((95%CI: 1.7, 10.9), p = 0.002); 4 h of HFNC, OR = 6.5 (95%CI: 2.5, 16.8), ( p < 0.001); and 6 h of HFNC, OR = 4.9 (95%CI: 1.9, 12.7), ( p = 0.001).
Conclusion
In children with ICCs, almost half fail HFNC. Mortality was high in those who fail HFNC. The FLOX score, specifically a FLOX ≥ 0.20 is associated with increased odds of failing HFNC in our ICC cohort.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Indiana University School of Medicine, Indianapolis, Indiana, USA.
- Department of Pediatrics, Division of Critical Care, Indiana University School of Medicine, Indianapolis, Indiana, USA.
- Riley Hospital for Children at IU Health, Indianapolis, Indiana, USA.
- Regenstrief Center for Biomedical Informatics, Indianapolis, Indiana, USA.
ORCID-Profile: Michelle A Mai, Colin M Rogerson, Courtney M Rowan
Förderung
- NHLBI NIH HHS
- National Heart, Lung, and Blood Institute
Zitieren
APA
Mai, M. A., Rogerson, C. M., & Rowan, C. M. (2026). Development of the Novel FLOX Score to Assess Risk of Intubation in Children With Immunocompromising Conditions Receiving High Flow Nasal Cannula. Pediatric Pulmonology. https://doi.org/10.1002/ppul.71814
Vancouver
Mai MA, Rogerson CM, Rowan CM. Development of the Novel FLOX Score to Assess Risk of Intubation in Children With Immunocompromising Conditions Receiving High Flow Nasal Cannula. Pediatric Pulmonology. 2026. doi:10.1002/ppul.71814
BibTeX
@article{Mai2026,
author = {Mai, Michelle A and Rogerson, Colin M and Rowan, Courtney M},
title = {Development of the Novel FLOX Score to Assess Risk of Intubation in Children With Immunocompromising Conditions Receiving High Flow Nasal Cannula},
journal = {Pediatric Pulmonology},
year = {2026},
doi = {10.1002/ppul.71814}
}
EUVIMED